Improving lives and communities: Morneau Shepell releases annual CSR Report

Prioritizing the health and productivity of people – the heart of every successful organization – is more important than ever through this year of uncertainty

TORONTO, Oct. 20, 2020 /CNW/ - Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today released its annual Corporate Social Responsibility (CSR) Report. The company's second annual report outlines CSR activities completed in 2019 and over the first six months of 2020, including environmental, social and governance performance and significant advances in key areas such as employee mental health and wellbeing, sustainability initiatives and community investments that support mental health and education.  

"Our priority continues to be protecting the health, safety and wellbeing of our employees and clients, as well as creating solutions to improve lives globally," said Stephen Liptrap, president and chief executive officer. "The transformational investments we have made in recent years have made our work and workforce flexible in ways that have greatly contributed to our success in adapting to COVID-19. This has ultimately translated into better supporting our clients, their teams and families during an especially stressful time."

In addition to an expanded environmental policy and community-focused investments, Morneau Shepell's CSR strategy remains strongly focused on providing the much-needed services and resources that broader communities require to successfully navigate the challenges that COVID-19 has created. In 2020, Morneau Shepell introduced services and resources designed to support Canadians during this time, including WellCan, an online hub of wellbeing resources, and AbilitiCBT™, an internet-based cognitive behavioural therapy program designed to address the uniquely challenging aspects of a pandemic. The company also opens its free crisis hotline for communities affected by traumatic events, such as natural disasters, fatal accidents and mass shootings.

In the first half of 2020, Morneau Shepell also launched the Mental Health Index™, an innovative survey that measures mental health levels in the employee population in the four key jurisdictions where the company operations: Australia, Canada, the United Kingdom and the United States. 

Inclusion and diversity at the forefront
In 2019, Morneau Shepell established an Inclusion and Diversity (I&D) Council and developed a strategy, which was expanded earlier this year to form an Anti-Racism Task Force, adding to the company's existing advancements in gender equality and diversity. The company also enthusiastically pledged its support for the CEO Action Pledge in the United States and the BlackNorth Initiative in Canada – two leading initiatives that work to meaningfully address anti-Black racism and advance diversity and inclusion in the workplace. 

"We are proud to have a gender diverse team. In 2019, women occupied more than one third (38 per cent) of our Board of Directors and one quarter (27 per cent) of executive officer roles – a number that is significantly higher than the 10 per cent reported for women working in the C-suite across Canada's 100 largest publicly traded companies last year," added Liptrap. 

Among other advancements in CSR, Morneau Shepell achieved a ranking of seventh out of 224 companies in the S&P/TSX composite index and a total score of 96 out of 100 points in The Globe and Mail's annual corporate governance assessment, reflecting the company's strong governance framework. The Company recently became a supporter of the United Nations Global Compact.

Morneau Shepell aims to improve one billion lives
Today, Morneau Shepell's work reaches nearly one hundred million people through its employee and family assistance programs, the pension plans it administers, the volunteer work of its employees and its community investments. The company also launched its Improving 1BillionLives program, which includes contributions from the employee engagement and community volunteer programs.

"Improving one billion lives is an aspiration of our team in the long term," added Liptrap. "We firmly believe that this an attainable goal and it is one that drives our employees today in their activities and will continue to do so in the future."

The full Corporate Social Responsibility Report can be found at: https://www.morneaushepell.com/ca-en/corporate-social-responsibility. 

About Morneau Shepell
Morneau Shepell is a leading provider of technology-enabled HR services that deliver an integrated approach to employee wellbeing through our cloud-based platform. Our focus is providing world-class solutions to our clients to support the mental, physical, social and financial wellbeing of their people. By improving lives, we improve business. Our approach spans services in employee and family assistance, health and wellness, recognition, pension and benefits administration, retirement consulting, actuarial and investment services. Morneau Shepell employs approximately 6,000 employees who work with some 24,000 client organizations that use our services in 162 countries. Morneau Shepell is a publicly traded company on the Toronto Stock Exchange (TSX: MSI). For more information, visit morneaushepell.com.

SOURCE Morneau Shepell Inc.

One Million Masks Donated in the GTA. Millions of People Protected: DYMON Self Storage Announces Face Mask Donation Initiative

As COVID-19 cases surge, DYMON Self Storage is making one million face masks available to charitable organizations and communities across the GTA

TORONTO, Oct. 20, 2020 /CNW/ - Today, DYMON Self Storage ("DYMON" or "the company") and its owners Glen Luckman and Brent Wilson, announced a donation of one million commercial grade face masks to charities and community groups in the Greater Toronto Area in order to combat the spread of COVID-19. DYMON Self Storage's initiative is designed to protect vulnerable residents of the GTA in the face of rising case numbers by distributing DYMON face masks to front line workers and clients of charities and community groups. 

"Like everyone, we are very concerned with the rise in COVID-19 cases across the GTA and want to ensure the health and safety of vulnerable people within our community by providing commercial grade face masks," said Glen Luckman, CEO of DYMON. "DYMON Self Storage's donation of certified face masks to the GTA is a reflection of our corporate commitment to philanthropy and our pledge to donate 50% of profits and 50% of our value creation to charity over time."

"As a community partner, it is essential that we take collective and decisive action to fight the pandemic," added Brent Wilson, President of DYMON. "Wearing a certified DYMON face mask is a critical preventative measure that we can all undertake to slow and stop the spread of COVID-19, particularly when used universally throughout our community."

DYMON's commercial grade face masks are in the GTA today, and are ready to be delivered immediately to organizations and communities across the region directly from the company's state-of-the-art climate-controlled self storage facility in Etobicoke. 

Over the past three weeks DYMON Self Storage has donated over 100,000 face masks to more than 40 charitable and community organizations in the City of Ottawa, including The Ottawa Mission, The Ottawa Housing Corporation, and the Ottawa Community Immigrant Services Organization. DYMON's donation of one million face masks to the GTA is an expansion of this initiative, and the company believes it is the largest single private corporate donation of PPE in the GTA. Through its donation, DYMON Self Storage will be providing the equivalent of one certified face mask for every six GTA residents. 

Made to exacting standards, DYMON's commercial grade face masks are individually packaged and have a five-layer construction designed to filter at least 95% of particles to help reduce the exposure to airborne contaminants, including the coronavirus. Featuring a better seal against the wearer's face than surgical or cotton face masks, the DYMON face mask design ensures that individuals are "protected from others" and "others are protected from them". 

Through its donation, DYMON Self Storage aims to help as many vulnerable people served by GTA charities and community organizations as possible. If you are a charity or community group that needs protective face masks to safeguard your employees and clients, please visit DYMON Self Storage online at dymon.ca or contact the DYMON Self Storage team at 416.844.3874.

ABOUT DYMON Self Storage

A proudly Canadian-owned and operated company, DYMON Self Storage is rapidly expanding its footprint in the GTA with plans to build more than eighty (80) facilities comprising in excess of 10 million sq. ft. DYMON's current portfolio consists of the world's largest storage facility in Etobicoke (across from IKEA), as well as a facility in Brampton. DYMON Self Storage will also be opening another of its state-of-the-art facilities in Oshawa before the end of the year. Through its Guest-focused approach, DYMON is changing the entire storage industry.

DYMON Self Storage has become Canada's most innovative storage operator by offering residential and business Guests unparalleled service and innovative storage solutions. DYMON is changing the way people think about storage by offering a variety of sophisticated, mixed-use projects in combination with its state-of-the-art storage facilities. All of DYMON's facilities offer full climate and humidity control, 24/7 access with extended retail hours and overnight surveillance, boardroom rentals, drive through bays where Guests can be protected from weather conditions, and FREE movers, truck and driver at move-in.  DYMON has managed to create a strong and differentiated presence by offering other value-added services, including moving and packing supplies, shredding services, safe deposit vaults and the unique DYMON retail store, which is now available to shop online and features over 2,500 home décor and organizational products along with custom closet solutions. In addition, DYMON recently launched DYMON Work Refined, its new collaborative workspace business, and DYMON Wine Cellar, its unique wine club and storage experience, at its flagship facility in Etobicoke, ON.   

SOURCE DYMON Self Storage

Poor people demand a just COVID stimulus package during Moral Monday focus on battleground states 

A 29-year-old mother of four from Kansas wants U.S. senators who are refusing to pass a just COVID stimulus package to know this about her life: She had decided last year that she would have to die because she couldn’t afford the $4,000 she needed to start treatment for stage 4 uterine cancer. 

“In the richest nation we should not resign ourselves to die because we can’t afford to beat our cancer,” Shelby Fedrenbacher said during the national Moral Monday Digital March on McConnell’s Senate held by the Poor People’s Campaign: A National Call for Moral Revival. 

People from several battleground states spoke during the program, along with actors/activists Alyssa Milano and Bradley Whitford. In addition to Kansas, people from Mississippi, Michigan, Pennsylvania, Maine, North Carolina, South Carolina, Kentucky, Texas and Kansas talked about their lives during COVID-19 and why they’re determined to vote, no matter the obstacles presented by the pandemic or voter suppression tactics. 

People have flooded McConnell’s office phones in Kentucky and Washington, D.C., with calls for several weeks. This week, the Poor People’s Campaign asked them to flood the offices of all U.S. senators on the same Monday as when the House and Senate were negotiating yet again over a COVID-19 relief package. 

Fedrenbacher, who was diagnosed with cancer last year, said she “was so depressed I would look at my four children every day and just decide that I am just going to die as peacefully as I can. I don’t know what else to do here.” 

Friends rallied around her and raised the $4,000, but Fedrenbacher wouldn’t have had to rely on their goodwill for her healthcare if Kansas had expanded Medicaid. It’s one of 12 states that has not taken this basic step to guarantee health insurance to millions of more Americans. 

A lack of healthcare, a pandemic, the stacking of the Supreme Court. None of this has to happen, Rev. Barber said. 

“Everything we see now is man created, even the way in which this pandemic is hurting us is man-created,” Rev. Barber said. “The fact that we are talking about stacking the Supreme Court and not passing a stimulus. All of that is created by politicians, by a human being, by the president, by Mitch McConnell: It does not have to be.”

“Not only does it not have to be, we have the power to change.”

The 8 million people who have fallen into poverty during the pandemic are on top of the 140 million who were already poor and low-income, Rev. Theoharis said. And “that's on top of the growing sections of people who are one fire, one storm, one healthcare crisis, one job loss away from deep poverty,” she said. And this is in the richest country in human history, this is with a Senate that has the means, has the power to make it all better and make it all OK.” 

Both Whitford and Milano decried the state of the country and urged people to vote. 

“I have watched in horror as over the last decades the Koch brothers have pumped money into my state to suppress the vote,” Whitford said. “At least 100,00 people who wanted to vote in Wisconsin were disenfranchised all because of Republican chicanery ....we need to be talking about a long active strategy by Republicans to suppress the vote.” 

Milano described voting as one way that Americans protect each other. 

“We need an America where everyone can afford rent, can put food on the table and set aside some savings for a rainy day,” she said. “We need an America where people don't perpetuate these injustices and continue to march forward” each day. 

Morneau Shepell announces new appointment to Board of Directors

TORONTO, Oct. 19, 2020 /CNW/ - Morneau Shepell is pleased to announce the appointment of Robert Courteau to its Board of Directors, effective today. Mr. Courteau most recently served as the CEO of Altus Group, a leading provider of independent advisory services, software, and data solutions to the global commercial real estate industry.

"On behalf of the Board and the Company, it's a pleasure to welcome Robert," said Jill Denham, Chair of the Board. "We are thrilled to welcome an executive who has a deep global background with both digital transformation skills and broad experience with SaaS based business models. His command of data markets, analytics and information services platforms will be important for the company as we move our strategic plan forward." The Board and management will also value his executive insights, growth orientation and managerial depth to support the many market opportunities for the company. Prior to his most recent position at Altus Group, Mr. Courteau was President, North America and Global Chief Operating Officer at SAP AG, a global market leader in enterprise application software.

Mr. Courteau is a member of the Board of Directors of Kinaxis, and a past member of the Board of Real Matters. Mr. Courteau holds a Bachelor of Commerce degree from Concordia University and was awarded an Honorary Doctor of Laws degree from Concordia University in 2011.  In recognition of his commitment to education and endorsement of international standards and regulation, Robert was awarded a Fellowship with RICS (FRICS) in 2014. Mr. Courteau is also the Vice Chair of the Holland Bloorview Hospital Foundation.

The Company also announces that Michele Trogni has stepped down from the Board of Directors, effective September 30, 2020. "Michele's 30-year career of building businesses, along with her expertise in data insights, analytics and technology solutions have been valuable to the Company," said Denham.  "I'd like to thank Michele for her many contributions to the success of the company during her tenure on the Board."

About Morneau Shepell Inc.

Morneau Shepell is a leading provider of technology-enabled HR services that deliver an integrated approach to employee wellbeing through our cloud-based platform. Our focus is providing world-class solutions to our clients to support the mental, physical, social and financial wellbeing of their people. By improving lives, we improve business. Our approach spans services in employee and family assistance, health and wellness, recognition, pension and benefits administration, retirement consulting, actuarial and investment services. Morneau Shepell employs approximately 6,000 employees who work with some 24,000 client organizations that use our services in 162 countries. Morneau Shepell is a publicly traded company on the Toronto Stock Exchange (TSX: MSI). For more information, visit morneaushepell.com.

SOURCE Morneau Shepell Inc.

Health Charities and Patient Groups Join Together to Protect Access to Breakthrough Medical Treatments in Canada

Patients shut out of process leading to the release of revised guidelines by the Patented Medicine Prices Review Board.

TORONTO and MONTREAL, Oct. 19, 2020 /CNW/ - As exciting medical advances continue to be made around the world, there is a shared concern that people in Canada will not be able to access these scientific breakthroughs. Leading health charities and patient groups that represent 2.9 million patients across Canada are working together to raise concerns about revised guidelines expected by the Patented Medicine Prices Review Board (PMPRB) this week, that will limit access to treatments that could improve and even save lives. 

"The PMPRB announced briefings for media and industry on the revised guidelines, yet patients, who are at the heart of policy questions around access to new medications, were not considered. The fact that patients have been overlooked has been a consistent problem from the start of the PMPRB consultation process that began in 2017. Patient groups have been saying for years that this consultation process has failed the patient community, and our views have not been properly taken into account in the development of the proposed changes. The cystic fibrosis (CF) community is the first to experience how these changes will limit access to new, life-changing medicines, but all Canadians are right to be worried," said Kelly Grover, President and CEO of Cystic Fibrosis Canada.

"We have seen what the CF community has experienced, and we are concerned that the vision loss community will face this situation too. We are concerned that we won't be able to access the new medications, gene and cell therapies that restore sight and avoid blindness," said Doug Earle, President and CEO of Fighting Blindness Canada. 

Canada has prided itself on universal access to healthcare. This means that when diagnosed with an illness, Canadians can receive best-in-class treatment. According to a recent survey commissioned by the group, a majority of Canadians (70 per cent) recognize that new, innovative prescription medicines developed over the past 20 years have improved the lives of Canadians.ⁱ

But that access is at risk due to the PMPRB changes scheduled to take effect in January 2021. There is a fear that doctors will only have cheaper, older and less effective drugs available to them to treat patients as new drugs will not be made available in Canada. There is a worry that there will be fewer clinical trials taking place locally when patients need new medicines to try.

These changes will result in wider inequities, prompting those that can afford it to leave the country for better treatment options. And when Canadian families are faced with a dreaded diagnosis, they will need to make heartbreaking decisions. 

The same public opinion survey showed that 7 in 10 people in Canada had not even heard of the proposed changes to how prices for new prescription medicines in Canada are reviewed and approved.ⁱⁱ Given the implications of these changes on people's health, the public should be consulted by government so that all Canadians can share their opinions on government's plans. 

To give Canadians the best health care possible, the coalition is asking that all stakeholders collaborate for a workable solution where the patient is at the center. This means the pharmaceutical industry needs to find a way to lower prices. And government needs to prioritize human lives over saving costs. Eighty-two per cent of Canadians agree with this approach.ⁱⁱⁱ

The patient organizations behind the new campaign, "Protect Our Access", include:

• ALS Society of Canada 
• Canadian Cancer Survivor Network 
• Coalition Priorité Cancer au Québec 
• Colorectal Cancer Canada 
• Cystic Fibrosis Canada 
• Diabetes Québec
• Fighting Blindness Canada 
• Lung Health Foundation 
• MitoCanada 
• Ovarian Cancer Canada 
• PROCURE – The Force Against Prostate Cancer 
• Québec Breast Cancer Foundation   
• Leukemia & Lymphoma Society of Canada 

These 13 health charities and patient groups are calling on government to strike the right balance of both economic sustainability and ensuring Canadians families can access breakthrough treatments, both now and in the future. 

A majority of Canadians (80 per cent) believe the government should ensure that Canadians have access to new medicines for rare diseases in Canada at the same time as citizens in other countries get access to them.^iv Let's work together to protect this right.

To learn more and have your voice heard on this important issue, visit protectouraccess.ca.

About Protect Our Access

A group of patient organizations have come together to represent the voice of the patient in policy discourse with regards to access to innovative medicines. The objective is to communicate to government and the public the importance of protecting timely and equal access to innovative medicines for patients; striking the right balance between reducing costs and ensuring Canadians continue to have access to new medicines. In addition to the non-profits investing their own resources, a portion of the campaign funding has been made possible through unrestricted grants from two innovative medicines companies.

About the Public Opinion Survey

Hill+Knowlton Strategies research group, Perspectives+, conducted a study with a total of n=996 adult residents from across Canada. The survey was conducted online between October 2-6, 2020. The sample was randomly drawn from Leger's web panel of potential survey respondents. Post-stratification weights were applied to the sample based on 2016 census population figures to ensure representation by province of Canada, age and gender. An associated margin of error for a probability-based sample of this size would be ±3%, 19 times out of 20.

SOURCE Protect Our Access

Bioclean Innovation and rep-L® Antimicrobials partner together to launch a new line of bio-based antimicrobial products with extended residual protection against COVID-19

VANCOUVER, BC, Oct. 19, 2020 /CNW/ - Bioclean Innovations Inc, a Biotech startup focused on innovative antimicrobial solutions to combat disease outbreaks has partnered with rep-L^® Antimicrobials, to launch a powerful but non-toxic bio-based antimicrobial product line. 

Our rep-L-based disinfectants are designed to create a new methodology for addressing the infection control challenges facing the education and long-term health care sectors today. The SARS-CoV-2 virus responsible for the COVID-19 pandemic is one of an increasing number of pathogens and antibiotic-resistant infections society is facing.

Schools, universities, and care homes rely on a frequent cleaning and disinfection process which now requires more cleaning and disinfectant products and more labor while still leaving the risks of microbial transmission from contamination occurring on the surface in between disinfection cycles. 

Bioclean has developed a range of products, including continuously-active disinfectant, hand sanitizer, and disinfectant wipes that can kill and protect against viruses, bacteria, and fungi for thirty (30) days and longer, eliminating the need for frequent disinfection and providing effective, long-lasting protection on high touch surfaces and hands. 

Bioclean products are made using rep-L^®, a novel plant-based technology that rapidly kills microbe cells, which also prevents antimicrobial resistance. Bioclean products are scientifically tested to continuously kill 99.99% of viruses, bacteria, fungi and the Human Corona Virus (229E) under one minute on contact and protect most surfaces for thirty (30) days and longer.

Bioclean products are particularly suitable for use in spaces around children or the elderly, eliminating the risk of microbial transmissions with potentially contaminated surfaces and reducing pressure on school and care staff. 

Mohsin Kazi, Founder of Bioclean Innovations Inc, noted that "It is an exciting partnership that brings the potential of rep-L^®-based surface infection control to a practical application for the first time. Plant-based, non-toxic, and highly effective, it's a technology that is ideal for the educational, care homes, and practically in any shared public facility. We know that it can provide effective infection control against COVID-19, of course, but also protect against a broad range of virus, bacterial and fungal transmissions."

Bioclean products are currently undergoing approvals from Health Canada and US EPA. 

You can find out more about Bioclean, its partnership with rep-L^®, and the range of surface infection control solutions at www.bclean.ca. 

SOURCE Bioclean Innovations Inc

City of Mississauga Applauds Roche Canada Jobs Investment in Life Sciences Industry

MISSISSAUGA, ON, Oct. 19, 2020 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) has announced a major jobs investment into Ontario's life sciences industry that will bring up to 500 highly skilled and specialized full-time positions to the City of Mississauga. Roche Canada's $500 million dollar investment over five years will establish a Global Pharma Technical (PT) Operations site at its Mississauga pharmaceutical headquarters. 

"At a time when Canada and the world are looking to the life sciences sector to lead in testing, treatment and post-pandemic economic recovery, I am proud that Roche Canada has decided to grow and expand their business here in Mississauga," said Mayor Bonnie Crombie. "Roche is a global pioneer in pharmaceuticals and diagnostics. Not only will this investment support jobs and attract talent, but it also reinforces Mississauga's position as a global, internationally recognized leader in life sciences. Our local economy has greatly benefitted from our thriving life sciences sector, a place where researchers can not only make medical breakthroughs but where products can be commercialized and brought to market."

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. 

"Mississauga was selected for this investment based on a strong competitive business environment, exceptional talent pool, and a government committed to fostering growth in the sector," says Ronnie Miller, President and CEO of Roche Pharmaceuticals, Canada. "We applaud the hard work done by the Government of Ontario and the Premier's Office to foster a business environment that can compete internationally to attract investment opportunities, and Roche's commitment to add up to 500 specialized positions is a direct result of these positive changes. Without the support of all three levels of government, the Mississauga Board of Trade, Life Sciences Ontario, and Invest in Canada, who are all active advocates for a thriving sector, this investment would not have been possible." 

Mississauga is the second largest Life Sciences Sector in Canada by employment, with more than 470 companies employing over 25,000 people. 

"Mississauga is the first Canadian municipality to have a five year Life Sciences Cluster Strategy and Action Plan that focuses on establishing Mississauga as the premier Canadian destination for the commercialization of life sciences products, technologies and services," said Bonnie Brown, Director of Economic Development. "Our commitment to growing Mississauga's Life Sciences cluster has been instrumental in helping us achieve our economic goals and attracting new investment."

Roche Canada states the investment will create new and exciting employment opportunities, in particular for recent graduates of Ontario's strong science, technology, engineering and math academic institutions who will have the opportunity to impact the development of Roche's medicines from early stages through to patient use around the world. 

For more information about Mississauga's Life Sciences Cluster, visit thefutureisunlimited.ca. 

SOURCE City of Mississauga

Evidence Partners Launches New Literature Review Automation, Data Integration and Project Dashboarding Capabilities for DistillerSR

New Capabilities Build on DistillerSR's Market Leading Artificial Intelligence and Workflow Automation for Reviews

OTTAWA, ON, Oct. 19, 2020 /CNW/ - Evidence Partners Inc., provider of the world's first AI-enabled literature review automation software, DistillerSR, today announced new capabilities that further improve the way researchers can reduce the time, administrative friction and cost to complete their literature reviews. Combining DistillerSR's AI and workflow automation, these new capabilities provide customers with automatic email alerts from online content services, direct connections to full-text articles from e-libraries, integration with third-party software platforms, and detailed cross-project dashboarding for greater visibility into reviews on an enterprise scale. 

"Literature reviews continue to grow larger, more complex, and broader in their application, especially in highly regulated healthcare markets," said Peter O'Blenis, CEO, Evidence Partners. "Through the continued elimination of manual processes, and by leveraging AI in the literature review process, we are helping researchers to complete their important work faster, more accurately, and more cost-effectively."   

Along with OpenConnect, DistillerSR now has OvidConnect and EBSCOConnect to allow customers to automatically receive and process email alerts from these content services, making the process of maintaining and updating reviews faster and less error prone. For organizations using in-house e-libraries, DistillerSR's new Custom OpenURL capability allows researchers to link directly to their library's full-text content from within their DistillerSR reviews. This support for the central management of full- text articles can lessen the need to copy them and can reduce copyright compliance issues. 

To more seamlessly integrate the literature review process with third-party platforms, DistillerSR has created the industry's first publicly accessible API. The API allows customers to securely integrate directly with a broader technology ecosystem, including but not limited to, safety databases, external AI and predictive analytics applications, reporting systems, and data lakes, among others – the first of its kind in the literature review industry.  

Cross-project dashboards, meanwhile, enable customers to easily view and access review assignments across all projects from a central location, greatly improving oversight into reviewers' progress and visibility into underutilized talent.

DistillerSR is used by pharmaceutical and medical device companies, contract research organizations, as well as universities, governments, and NGOs. The cloud-based platform brings together AI and sophisticated workflow automation to make completing systematic literature reviews faster, more accurate and more cost effective than any other method. As a result, DistillerSR enables researchers to quickly produce high quality evidence to inform critical health policies, clinical practice guidelines, and regulatory submissions.  

About Evidence Partners
For more information about Evidence Partners and DistillerSR, visit www.evidencepartners.com.

SOURCE Evidence Partners

How to Train Your Body in the Comfort of Your Own Home

You do not have to go to the gym in order to get a good workout. You can get yourself in great shape at home. There are several things that you can do in order to train your body in the comfort of your own home.

Do 150 Minutes of Cardio Activity Every Week

The American Council on Exercise recommends that you get 150 minutes of exercise per week. This is equivalent to 2.5 hours. Any type of exercise that you do that gets your heart rate up will greatly benefit you. This includes kickboxing, cycling, dancing, and walking.

Do Interval Training

Interval training is a type of exercise that mixes high-intensity cardio with low-intensity cardio. Interval training sessions are typically only 20 to 30 minutes long. However, you can burn more calories during an interval training than you do during a standard cardio session. Interval training also raises your metabolism, so you burn more calories while you are at rest. You should do interval training twice a week.

Use Strength Training Equipment

Strength training is an important part of your exercise regimen. It not only helps strengthen your muscles, but it can also help you burn fat. Additionally, it can help you build lean muscle. You should invest in  strength training equipment. It is a good idea for you to use strength training equipment at least twice a week. You should start off with a small amount of weight. You can gradually increase your weight after you have been strength training for a while.

Stretch

Stretching should be a part of everyone’s exercise routine. You should exercise before and after your workout. Stretching helps your body warm up and prepare for the workout. It also helps your body cool down after a workout. Additionally, there are numerous other benefits that you can reap from stretching. It will reduce the soreness that people often feel the day after their workout. It can also improve your posture and balance as well as increasing blood flow.

You can get yourself in great shape without going to the gym. It is a good idea for you to do 150 minutes of aerobic exercise per week. You should also do interval training twice a week. Strength training is another activity that you will need to add to your regimen. Furthermore, you will need to stretch before and after your workout.